Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,400
-220 (-1.89%)
At close: Apr 28, 2026
-9.24%
Market Cap 203.99B
Revenue (ttm) 272.42B
Net Income (ttm) 6.90B
Shares Out 17.92M
EPS (ttm) 375.00
PE Ratio 30.35
Forward PE n/a
Dividend 155.00 (1.33%)
Ex-Dividend Date Dec 29, 2025
Volume 90,746
Average Volume 107,463
Open 11,590
Previous Close 11,620
Day's Range 11,370 - 11,750
52-Week Range 10,780 - 16,240
Beta 0.63
RSI 39.41
Earnings Date May 13, 2026

About KRX:007570

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and be... [Read more]

Sector Healthcare
Founded 1946
Employees 666
Stock Exchange Korea Stock Exchange
Ticker Symbol 007570
Full Company Profile

Financial Performance

In 2025, KRX:007570's revenue was 272.42 billion, an increase of 1.39% compared to the previous year's 268.68 billion. Earnings were 6.90 billion, a decrease of -23.55%.

Financial Statements

News

There is no news available yet.